Skip to main content
Stonvex
Loading…
Home
Activity
Screener
Portfolio
Community
Stonvex publishes market data and research only.
Not investment advice. Not a registered investment advisor.
Read disclaimer
.
Stonvex
Search…
⌘K
Search…
⌘K
Log in
Get Started
← Back to rankings
SABS
Live
Save
Overview
Financials
Filings
Earnings Calls
Short Interest
Ownership
Ratings
Peers
News
Loading latest news…
52w high -43.9%
☁️ News word cloud
Top words across the last 50 articles for this ticker.
biotherapeutics
nasdaq
clinical
diabetes
announced
type
human
trading
platform
high
results
compared
rating
last
million
stage
biopharmaceutical
2024
novel
nyse
SABS
SAB Biotherapeutics, Inc. Common Stock
Stonvex
StonvexStonvexStonvexStonvex